Lowther | Walker represents healthcare providers, executives, and organizations facing federal hospice fraud investigations. Our attorneys possess deep expertise in the complex regulatory frameworks governing hospice care. Our clients include doctors, medical directors, agency owners, nurses, and all other hospice medical services providers facing criminal investigations.
We defend hospice operations against a wide range of administrative, civil, and criminal healthcare fraud allegations, focusing on:
Eligibility & Certification Disputes: Challenging claims of improper physician certifications/recertifications of terminal illness and billing for patients who allegedly do not meet Medicare eligibility criteria.
Clinical Documentation Audits: Defending against accusations of falsified medical records, inaccurate clinical assessments, or altered nursing logs.
Reimbursement & Level-of-Care Fraud: Resolving Medicare and Medicaid disputes regarding improper utilization of care tiers (e.g., Routine Home Care vs. General Inpatient Care) and aggressive census management.
Anti-Kickback & Referral Scrutiny: Countering allegations of unlawful referral arrangements and financial relationships under the Anti-Kickback Statute (AKS).
False Claims Act & Whistleblower Defense: Defending qui tam lawsuits initiated by whistleblowers and navigating high-exposure False Claims Act (FCA) litigation.
Compliance & Parallel Proceedings: Handling corporate compliance failures, internal investigations, OIG self-disclosures, and parallel civil, administrative, and criminal healthcare fraud proceedings.
No-obligation. Fully confidential.
Call Us Today: (404) 496-4052
Led by Federal Healthcare Fraud Team Leads Joshua Sabert Lowther, Esq. and former DOJ Prosecutor Murdoch Walker, II, Esq., Lowther | Walker’s defense attorneys bring 30 years of high-stakes federal trial experience to hospice fraud litigation. The team leverages former FBI, HHS-OIG, and IRS-CI special agents to execute proprietary shadow investigations and forensic billing audits.
When your hospice services company faces action from the Medicare Strike Force and Medicaid Fraud Control Units (MFCUs), our trial lawyers can respond. We systematically dismantle complex healthcare enforcement actions and proactively manage audits and investigations to mitigate penalties.
HHS-OIG and FBI investigated our client, the former director of a national laboratory, for Healthcare Fraud and Money Laundering based on their alleged participation in a scheme to defraud Medicare of approximately $100 million in […]
The USDA-OIG investigated our client, a public official, for Bank Fraud, Wire Fraud, Mail Fraud, and Money Laundering, alleging that the client allegedly conspired to obtain over $1 million in pandemic subsidies and loans. Despite […]
Investigation terminated; no prosecution. DOJ notified our client, the CEO of a major hospital network, that he was the target of a multi-million-dollar healthcare fraud investigation related to “Medicare upcoding” that the FBI and HHS-OIG […]
Investigation terminated; no prosecution. DOJ notified our client that she was the target of a multi-million-dollar public corruption, money-laundering, and tax-fraud investigation that FBI and IRS-CI were conducting. The client’s former atto rney had arranged […]
Drug investigation terminated; $3 million seized recovered; probation for tax charges. DEA and IRS-CI searched our medical-doctor client’s pain clinic and residence for evidence of his overprescribing controlled substances to his patients and evading business […]
HHS-OIG and FBI investigated our client, the former director of a national laboratory, for Healthcare Fraud and Money Laundering based on their alleged participation in a scheme to defraud Medicare of approximately $100 million in […]
The USDA-OIG investigated our client, a public official, for Bank Fraud, Wire Fraud, Mail Fraud, and Money Laundering, alleging that the client allegedly conspired to obtain over $1 million in pandemic subsidies and loans. Despite […]
Investigation terminated; no prosecution. DOJ notified our client, the CEO of a major hospital network, that he was the target of a multi-million-dollar healthcare fraud investigation related to “Medicare upcoding” that the FBI and HHS-OIG […]
Investigation terminated; no prosecution. DOJ notified our client that she was the target of a multi-million-dollar public corruption, money-laundering, and tax-fraud investigation that FBI and IRS-CI were conducting. The client’s former atto rney had arranged […]
Drug investigation terminated; $3 million seized recovered; probation for tax charges. DEA and IRS-CI searched our medical-doctor client’s pain clinic and residence for evidence of his overprescribing controlled substances to his patients and evading business […]
When the Department of Justice (DOJ) Fraud Section, the HHS Office of Inspector General (HHS-OIG), or the FBI targets a hospice ecosystem, the government relies on a predictable playbook. They review data outliers, assume clinical bad faith, and use administrative metrics to build criminal indictments. At stake are corporate assets, your personal liberty, Medicare/Medicaid billing privileges, and your professional legacy.
Lowther | Walker is an elite, nationwide white-collar defense firm with fluency in the nuances of hospice operations. We understand that federal agencies routinely criminalize subjective medical prognoses and weaponize regulatory ambiguity. You require trial counsel with proven experience dismantling the government’s data-driven narratives.
Joshua Sabert Lowther, Esq., is a preeminent federal trial and appellate litigator who routinely defeats complex regulatory narratives before juries unversed in end-of-life care metrics. He has a definitive track record of securing acquittals and dismissals against the full weight of the federal government by exposing flaws in how prosecutors try to quantify human mortality.
Murdoch Walker, II, Esq., brings the invaluable perspective of a former DOJ Task Force Officer and federal investigator. He anticipates how the Medicare Fraud Strike Force deploys confidential informants, how they utilize Civil Investigative Demands (CIDs) to paralyze a company before it can react, and exactly where their investigative authority ends. This insider intelligence shapes our strategic maneuvers from day one.
We do not wait for an indictment to build a defense. Lowther | Walker actively disrupts federal momentum by deploying an elite network of former FBI, HHS-OIG, and IRS-CI special agents to conduct proprietary shadow investigations.
Isolating Exculpatory Evidence: We execute parallel forensic audits of your electronic medical records (EMR) and billing data, locking down favorable clinical proof before the government can mischaracterize it.
Neutralizing Data Analytics: Federal prosecutors rely heavily on data mining to flag hospices with long lengths of stay (LOS) or high readmission rates. Our forensic experts counter the government’s algorithms with patient-specific clinical realities.
Pre-Indictment Intervention: We aggressively engage with United States Attorneys early, using our findings to downgrade high-risk criminal targets into civil administrative resolutions before charges are ever filed.
Defending a hospice requires navigating a minefield of highly technical statutes where the line between an administrative error and a federal felony is entirely based on proving criminal intent. We possess total command over the core pressure points of hospice litigation:
The Subjectivity of Terminal Prognosis: Under the False Claims Act (FCA), the government must prove objective falsity. We consistently defeat fraud claims by demonstrating that a patient’s eligibility is a subjective clinical judgment protected by the independent medical opinions of certifying physicians.
Dismantling “Worthless Care” & Level-of-Care Theories: Prosecutors frequently allege upcoding regarding General Inpatient Care (GIP) or Continuous Home Care (CHC). We meticulously reconstruct nursing logs, crisis documentation, and symptom-management records to validate every dollar billed.
Insulating the Referral Pipeline: We aggressively defend against Anti-Kickback Statute (AKS) allegations targeting medical director agreements, marketer compensation structures, and nursing home relationships by establishing strict compliance with statutory safe harbors.
Because healthcare fraud enforcement is strictly a federal domain, our specialized trial counsel represents hospice providers, executives, and physicians across all 50 states. Whether your organization is facing a UPIC audit that has escalated to a criminal referral, an OIG grand jury subpoena, or a high-exposure qui tam whistleblower lawsuit, Lowther | Walker brings an uncompromising, sophisticated defense to any U.S. District Court in the nation.
Hospice fraud generally involves allegations that a provider knowingly submitted false or fraudulent claims to Medicare, Medicaid, or other government healthcare programs for hospice services.
Federal investigators commonly allege that providers:
Many investigations begin with whistleblower complaints, audits, employee reports, data analytics reviews, or referrals from Medicare contractors.
The DOJ Criminal Division’s Fraud Section indicted our client alongside nine other co-defendants in a historic, $1.4 billion pass-through billing conspiracy involving rural hospitals and toxicology laboratories. After a six-week initial trial resulted in a deadlocked jury and a declared mistrial, the government aggressively retried the case using new expert witnesses and additional cooperating co-conspirators. Lowther | Walker fiercely dismantled the prosecution’s secondary narrative during the subsequent four-week trial, securing a unanimous “Not Guilty” verdict on all counts and the full release of our client’s seized assets.
The DOJ, FBI, and HHS-OIG targeted the CEO of a major hospital network in a multi-million-dollar criminal investigation centering on systemic “Medicare upcoding” allegations. Recognizing the catastrophic professional and corporate stakes, Lowther | Walker immediately launched an independent corporate shadow investigation to review the underlying clinical data and coding practices. Our defense team compiled an exhaustive clinical rebuttal and successfully convinced the DOJ to completely terminate both the criminal and civil fraud investigations without a single charge being filed.
The HHS-OIG and FBI targeted a national laboratory director for alleged multi-million-dollar Anti-Kickback Statute violations and laundering $100 million in non-medically necessary molecular testing reimbursements. Lowther | Walker stepped in to conduct a comprehensive, independent forensic audit of the lab’s billing data, regulatory compliance structures, and clinical medical necessity frameworks. By presenting these exhaustive findings directly to federal prosecutors and investigating agents, our defense team completely neutralized the government’s theories and secured a total declination of prosecution.
Our client was targeted by the HHS-OIG for allegedly participating in a massive, $30 million nationwide “telemedicine” kickback scheme that defrauded Medicare through the billing of non-medically necessary durable medical equipment (DME) and genetic testing. Lowther | Walker proactively launched a deep-dive shadow investigation, aggressively auditing the telemedicine network’s clinical intake files and technical documentation. Through a series of highly sophisticated, pre-indictment evidentiary presentations to federal prosecutors, we successfully convinced the government to completely drop the investigation and decline prosecution.
The government indicted our client on Conspiracy to Commit Healthcare Fraud, Aggravated Identity Theft, and False Statements for allegedly submitting over $7 million in fraudulent Medicare claims. While co-defendants who pleaded guilty to the felony indictments received devastating prison sentences of up to 133 months, Lowther | Walker held the line through jury selection on the first day of trial. We leveraged our trial readiness to force the government into a historic compromise: pleading guilty to a minor Class B misdemeanor with a guaranteed sentence of probation and absolutely no restitution obligations.
Federal hospice fraud investigations rarely focus on a single individual. Prosecutors frequently target multiple participants within an organization.
Common targets include:
In large investigations, prosecutors often attempt to establish that management directed employees to admit ineligible patients or maintain inflated census numbers to increase Medicare revenue.
Healthcare fraud charges typically arise when federal prosecutors allege that a hospice provider knowingly submitted false or fraudulent claims to Medicare, Medicaid, or another government healthcare program. In hospice cases, these allegations often involve enrolling patients who were not terminally ill, billing for services that were not provided, falsifying clinical documentation, or certifying patients for hospice care despite evidence that they did not meet eligibility requirements. Convictions can result in significant fines, restitution orders, exclusion from federal healthcare programs, and lengthy prison sentences.
The False Claims Act is the federal government’s primary civil enforcement tool for recovering funds paid on allegedly fraudulent healthcare claims.
Hospice providers may face FCA liability when the government alleges they knowingly submitted false claims for reimbursement or caused others to submit them. Common allegations include billing for ineligible hospice patients, falsifying physician certifications, manipulating patient records, or retaining Medicare payments to which the provider was not entitled. These cases frequently originate from whistleblower (Qui Tam) lawsuits and can expose providers to treble damages and substantial statutory penalties for each false claim submitted. Lowther Walker’s False Claims Act defense attorneys have years of experience in hospice cases.
The Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving anything of value in exchange for patient referrals involving federally funded healthcare programs. In hospice investigations, prosecutors often examine relationships between hospice providers and physicians, hospitals, nursing homes, assisted living facilities, and marketing representatives.
Hospice fraud allegations under the AKS may involve consulting agreements, medical director contracts, free services, gifts, commissions, or other financial arrangements designed to influence referral decisions. Because claims generated through unlawful referrals may also be deemed false claims, Anti-Kickback investigations frequently lead to additional civil and criminal exposure.
Conspiracy charges allow federal prosecutors to pursue multiple individuals for the same healthcare fraud scheme, even if they did not personally submit claims or communicate with Medicare. In hospice cases, the government may allege that owners, executives, physicians, marketers, admissions personnel, and billing staff worked together to admit ineligible patients, falsify documentation, or conceal improper billing practices. The prosecution will often use emails, internal communications, witness testimony, and financial records to argue that participants knowingly agreed to further the alleged scheme.
Wire fraud and mail fraud statutes are among the broadest criminal laws available to federal prosecutors and frequently accompany hospice fraud indictments.
These charges arise when prosecutors allege that electronic communications, internet transmissions, telephone calls, emails, or mailed documents were used to further a fraudulent scheme. Because Medicare claims are submitted electronically and hospice operations routinely involve interstate communications, nearly every alleged billing scheme creates potential wire fraud exposure. Each transmission can potentially serve as a separate criminal count carrying significant penalties.
Federal false statement charges may be filed when investigators believe a provider knowingly made material misrepresentations to government agencies, auditors, Medicare contractors, or law enforcement officials. In hospice cases, allegations often involve inaccurate physician certifications, altered patient records, misleading audit responses, falsified clinical assessments, or statements made during interviews with federal agents.
Providers can face false statement charges even when the government ultimately cannot prove the underlying healthcare fraud allegations, making careful communication with investigators and auditors critical throughout an investigation.
Clients turn to Lowther | Walker for our firm’s background in defeating billing fraud claims. Government auditors and prosecutors often focus on billing activity associated with the four levels of hospice care.
Routine Home Care is the most commonly billed hospice service, and providers may face scrutiny when investigators question whether patients were eligible for hospice benefits.
Continuous Home Care provides significantly higher reimbursement and often becomes a focal point when investigators allege services were exaggerated or improperly documented.
General Inpatient Care is reserved for patients requiring short-term inpatient management of acute symptoms. Auditors frequently review whether GIP admissions met Medicare requirements.
Respite care allows temporary relief for caregivers. Investigators may examine whether admissions satisfied federal reimbursement criteria.
Additional billing reviews often involve:
The consequences of a hospice fraud investigation can be devastating.
Providers may face:
Even when criminal charges are never filed, civil enforcement actions can threaten the viability of a hospice organization.
The decisions made during the earliest stages of an investigation often have a significant impact on the outcome of the case.
If you learn that you are under investigation:
Investigators frequently seek interviews before charges are filed. Statements made during these conversations can become evidence later.
Destroying records, deleting emails, or altering patient files can create additional criminal exposure.
Understanding the facts before prosecutors formulate their theory is critical. Internal reviews often identify important evidence and witnesses.
Employees, former employees, and business partners may later become government witnesses.
Early intervention can influence charging decisions, negotiation opportunities, and overall case strategy.
Our attorneys represent hospice providers from the earliest stages of an investigation through trial when necessary. We routinely challenge allegations involving hospice eligibility determinations, medical necessity, physician certifications, billing practices, and whistleblower accusations.
We work with medical experts, former federal investigators, forensic auditors, and healthcare compliance professionals to identify weaknesses in the government’s case and build effective defenses before charges are filed.
When the HHS-OIG, UPICs, or the DOJ’s Medicare Fraud Strike Force target your hospice’s length-of-stay metrics, live discharge rates, or physician certifications, they are building a data-driven case to suspend your Medicare payments. The next step is exclusion from federal healthcare programs, seizure of your corporate assets, and pursuit of criminal indictments under the Healthcare Fraud Statute (18 U.S.C. § 1347) and the False Claims Act. Don’t wait for a formal grand jury subpoena. Get ahead of the investigators with Lowther | Walker.
Call Lowther | Walker immediately at (404) 806-7997 to speak with an experienced federal hospice fraud defense lawyer.
No-obligation. Fully confidential.
Call Us Today: (404) 496-4052
Lowther | Walker neutralizes Unified Program Integrity Contractor (UPIC) data-mining by stripping away statistical abstraction. We cross-reference algorithmic flags with granular electronic medical record (EMR) data. By proving discharges resulted from unpredictable clinical stabilization rather than intentional census churning, we legally dismantle the presumption of systemic billing fraud.
Under the False Claims Act (FCA), objective falsity cannot be based on a retrospective battle of expert opinions. Lowther | Walker asserts the subjective clinical judgment protection. We demonstrate that the certifying physician’s prognosis was legally valid at the time of election, backed by contemporaneous, localized clinical documentation.
We aggressively execute a parallel forensic shadow investigation using former FBI and HHS-OIG agents. By dissecting the relator’s allegations early, we present exculpatory clinical evidence to the DOJ Civil Division to secure a declination of intervention, exposing personal bias or administrative errors over corporate fraud.
Under the Controlled Substances Act and DEA regulations (21 C.F.R. § 1301.74(b)), distributors must design an SOM system to identify and halt orders of unusual size, frequency, or pattern. Failing to report and halt these red flag orders can lead to DEA registration suspension and civil penalties.
The government must prove an absolute failure to provide care. Lowther | Walker counters by reconstructing hourly nursing logs, symptom-management charts, and crisis-intervention notes. We prove the heightened GIP reimbursement tier was clinically necessary to manage acute, refractory symptoms that could not be treated in a routine residential setting.
We aggressively position the arrangement under the personal services safe harbor. Our defense details that compensation reflected Fair Market Value (FMV) solely for actual administrative and supervisory duties. We systematically decouple the financial terms from any volume or value of patient referrals or census growth.
Off-label promotion occurs when a manufacturer markets an FDA-approved drug or device for an unapproved indication. The DOJ prosecutes this under 21 U.S.C. § 331 as the introduction of a “misbranded” product into interstate commerce, though First Amendment protections for truthful scientific exchange provide a critical defense.
Your lawyer will immediately submit a robust, evidence-backed rebuttal to CMS challenging the reliability of the underlying fraud allegations. Simultaneously, we prepare for federal court intervention to block the suspension if the agency oversteps its statutory authority or relies on flawed data analytics.
No. Under the False Claims Act (FCA), clinical eligibility requires a subjective medical opinion, not an objective certainty. A retrospective review by a government-retained expert cannot establish “falsity” if the attending physician made a good-faith, contemporaneous clinical determination of a 6-month life expectancy based on the patient’s medical records.
The DOJ investigates the whistleblower’s allegations in secret while the lawsuit remains under seal. To safeguard the provider, Lowther | Walker immediately deploys former FBI and HHS-OIG agents to execute a confidential shadow investigation. We isolate the flawed data points early, presenting an aggressive rebuttal to the U.S. Attorney to secure a government declination.